Also trades as: MBX.TO (TSX) · $vol 0M
MBXBF OTC
Microbix Biosystems Inc.
1W: +2.8%
1M: +2.8%
3M: +3.2%
YTD: +26.9%
1Y: +18.5%
3Y: -17.2%
5Y: -46.5%
$0.22
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$37M
-1.7% ▼
5Y CAGR: +19.2%
Total Liabilities
$10M
-1.7% ▼
5Y CAGR: +1.4%
Shareholders Equity
$28M
-1.7% ▼
5Y CAGR: +33.3%
Cash & Investments
$12M
-6.4% ▼
5Y CAGR: +165.1%
Total Debt
$8M
+26.3% ▲
5Y CAGR: +5.5%
Net Debt
-$4M
+38.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10M | $13M | $12M | $13M | $12M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $10M | $13M | $12M | $13M | $12M |
| Net Receivables | $4M | $3M | $4M | $4M | $2M |
| Inventory | $4M | $5M | $6M | $6M | $9M |
| Other Current Assets | $0 | $31K | $56K | $643K | $656K |
| Total Current Assets | $19M | $22M | $22M | $24M | $24M |
| Property, Plant & Equip. | $8M | $9M | $0 | $10M | $10M |
| Goodwill & Intangibles | $2M | $1M | $4M | $4M | $4M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$10M | $332K | $9M | $0 | $0 |
| Total Non-Current Assets | $10M | $11M | $13M | $14M | $14M |
| Total Assets | $29M | $33M | $36M | $38M | $37M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $2M | $2M | $3M | $2M |
| Short-Term Debt | $2M | $111K | $111K | $111K | $5K |
| Deferred Revenue | $743K | $555K | $0 | $490K | $586K |
| Other Current Liabilities | $743K | $555K | $2M | $0 | $579 |
| Total Current Liabilities | $5M | $3M | $4M | $3M | $3M |
| Long-Term Debt | $4M | $5M | $6M | $6M | $7M |
| Other Non-Current Liab. | $0 | $0 | $299K | $250K | -$1M |
| Total Non-Current Liabilities | $5M | $6M | $7M | $6M | $7M |
| Total Liabilities | $10M | $8M | $11M | $10M | $10M |
| — Equity — | |||||
| Common Stock | $44M | $50M | $49M | $49M | $51M |
| Retained Earnings | -$39M | -$37M | -$37M | -$33M | -$36M |
| Accumulated OCI | $3M | $2M | $2M | $2M | $2M |
| Total Stockholders Equity | $19M | $25M | $25M | $28M | $28M |
| Total Liabilities & Equity | $29M | $33M | $36M | $38M | $37M |
| — Key Metrics — | |||||
| Total Debt | $8M | $6M | $7M | $6M | $8M |
| Net Debt | -$2M | -$8M | -$5M | -$7M | -$4M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |